Jingrong Jean is the founder of BlossomHill Therapeutics. BlossomHill Therapeutics has raised $173M in total funding. Latest round: Series B.
Jingrong Jean Cui is the Scientific Founder, President, and CEO of BlossomHill Therapeutics, a clinical-stage biopharmaceutical company focused on small-molecule cancer drugs. She is a former Pfizer chemist whose previous company was sold to Bristol Myers Squibb for $4 billion. Cui led the company to raise $173 million in total funding by early 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide